Fetal bovine serum premium 500 ML
Ended Awarded
- Contract number
- 75N91021F00001
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $16,250 firm fixed price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on May 5, 2021, for fetal bovine serum premium in 500 mL quantities. The contract, which was completed by May 27, 2021, was performed in Minneapolis, Minnesota, where R&D Systems is headquartered. No set-aside designation was used for this procurement, indicating open competition. R&D Systems, a subsidiary of Bio-Techne Corporation, is a for-profit manufacturer specializing in high-quality biological research materials, including proteins, antibodies, and laboratory supplies that support biomedical research across federal agencies within the National Institutes of Health ecosystem.
This award was issued under R&D Systems' existing $10 million BPA with the Office of Logistics and Acquisition Operations, valid through September 30, 2025, which enables flexible task order fulfillment across critical research domains including cancer research and infectious disease studies. Fetal bovine serum is a standard reagent widely used in cell culture applications across biomedical research and clinical investigations. R&D Systems has demonstrated substantial capacity as a federal supplier, with contract awards ranging from approximately $10,000 to over $445,000 across multiple NIH institutes and the National Cancer Institute, supporting diverse research initiatives including COVID-19 investigations and translational science programs.
Quick answers
Who was awarded contract 75N91021F00001?
75N91021F00001 was awarded to Research And Diagnostic Systems, Inc. by National Cancer Institute (National Institutes of Health) on May 5, 2021.
How much is contract 75N91021F00001 worth?
The government has obligated $16,250 on 75N91021F00001.
Is contract 75N91021F00001 an order under another contract?
Yes. 75N91021F00001 is a BPA call under HHSN263201600021B, a blanket purchase agreement.
Was contract 75N91021F00001 competed?
The extent of competition for 75N91021F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award